Reading Time: 2 minutes Can we use a DOAC in a patient with a BMI ≥40 kg/m2 without impacting efficacy or safety?
Lauren Igneri
Lauren Igneri
Critical care pharmacist and proud Rutgers University graduate. Enjoys rock climbing, cycling, travel, and lively discussions on the finer points of pharmacokinetics and critical care over a beer with friends.
-
-
Reading Time: 2 minutes [▶] Dysregulation of glucose control is observed frequently in critically ill patients due to numerous reasons including sepsis, stress response, and use of corticosteroids.
-
Reading Time: < 1 minute Do you know which critically ill patients need stress ulcer prophylaxis?
-
Reading Time: 3 minutes There’s an IV form of plavix??? Yes! Get all the info in this post by Dr. Lauren Igneri!
-
Reading Time: 5 minutes The Pre-brief Understanding of the COVID-19 disease process caused by the SARS-2-CoV virus is evolving. While the majority of cases…
-
Reading Time: < 1 minute The Pre-brief Expected Effects if ECMO on Antimicrobial Pharmacokinetics/Pharmacodynamics Determining the most appropriate dose of antimicrobials in the setting of…
-
Reading Time: 4 minutes The Pre-brief Benzodiazepines have long been the cornerstone of alcohol withdrawal management. However, phenobarbital is an overlooked treatment despite its…